Avstera Therapeutics
PrivateLast Round
Accelerator
Oct 13, 2023
Total Funding Raised
$9.55M
Company Overview
Avstera Therapeutics is a biotechnology company that develops therapies to address the significant needs of advanced cancer patients with limited or no treatment options.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avstera Therapeutics Comparables
Compare Avstera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SIRPant Immunotherapeutics | 80% | |
| United Immunity, Co., Ltd. | 78% | |
| Jubilant Pharmova Limited | 78% | |
Avstera Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Oct 13, 2023 | ||||
| Series A | Oct 2, 2023 | ||||
| Seed | Nov 9, 2022 |
Avstera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Pennsylvania Office of Investments | Seed |
| Togo Ventures | Series A |
| Backswing Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors grew 110% MoM, reaching 1.7K.
- Jul 2, 2025
Monthly visitors increased 2623% from 30 to 817.
Avstera Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avstera Therapeutics's valuation, stock price, and market status.